{"id":"https://openalex.org/W3105953293","doi":null,"title":"Pharmacovigilance 2019: Process Optimization and Role of Artificial Intelligence in GlobalPharmacovigilance","display_name":"Pharmacovigilance 2019: Process Optimization and Role of Artificial Intelligence in GlobalPharmacovigilance","publication_year":2020,"publication_date":"2020-01-01","ids":{"openalex":"https://openalex.org/W3105953293","mag":"3105953293"},"language":"en","primary_location":{"id":"mag:3105953293","doi":null,"is_oa":false,"landing_page_url":"https://www.iomcworld.org/articles/pharmacovigilance-2019-process-optimization-and-role-of-artificial-intelligence-in-globalpharmacovigilance.pdf","pdf_url":null,"source":{"id":"https://openalex.org/S2764552476","display_name":"International Journal of Applied Biology and P","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"International Journal of Applied Biology and P","raw_type":null},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5020274448","display_name":"Asha Kumari Jha","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Asha Kumari Jha","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5020274448"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.18830937,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"1","issue":"1","first_page":"1","last_page":"1"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":1.0,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":1.0,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11649","display_name":"Pharmaceutical industry and healthcare","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2910","display_name":"Issues, ethics and legal aspects"},"field":{"id":"https://openalex.org/fields/29","display_name":"Nursing"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10902","display_name":"Complementary and Alternative Medicine Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2707","display_name":"Complementary and alternative medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pharmacovigilance","display_name":"pharmacovigilance","score":1.0},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.9940000176429749},{"id":"https://openalex.org/keywords/artificial-intelligence","display_name":"artificial intelligence","score":0.6779999732971191},{"id":"https://openalex.org/keywords/uppsala-monitoring-centre","display_name":"Uppsala Monitoring Centre","score":0.9769999980926514},{"id":"https://openalex.org/keywords/adverse-event-reporting","display_name":"adverse event reporting","score":0.8299999833106995},{"id":"https://openalex.org/keywords/underreporting-of-adverse-events","display_name":"underreporting of adverse events","score":0.8849999904632568},{"id":"https://openalex.org/keywords/post-marketing-surveillance","display_name":"post-marketing surveillance","score":0.9459999799728394},{"id":"https://openalex.org/keywords/end-stage-renal-disease","display_name":"end-stage renal disease","score":0.8970000147819519},{"id":"https://openalex.org/keywords/dialysis-patients","display_name":"dialysis patients","score":0.9829999804496765},{"id":"https://openalex.org/keywords/drug-safety-profile","display_name":"drug safety profile","score":0.4359999895095825},{"id":"https://openalex.org/keywords/patient-safety","display_name":"patient safety","score":0.6990000009536743}],"concepts":[{"id":"https://openalex.org/C57658597","wikidata":"https://www.wikidata.org/wiki/Q1550789","display_name":"Pharmacovigilance","level":3,"score":0.9883541464805603},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6946772336959839},{"id":"https://openalex.org/C2777488183","wikidata":"https://www.wikidata.org/wiki/Q6900510","display_name":"Safety monitoring","level":2,"score":0.5154770016670227},{"id":"https://openalex.org/C2779328685","wikidata":"https://www.wikidata.org/wiki/Q1475557","display_name":"Patient safety","level":3,"score":0.4919717013835907},{"id":"https://openalex.org/C2780542314","wikidata":"https://www.wikidata.org/wiki/Q45959","display_name":"Adverse drug reaction","level":3,"score":0.45396292209625244},{"id":"https://openalex.org/C2993432071","wikidata":"https://www.wikidata.org/wiki/Q45959","display_name":"Drug reaction","level":3,"score":0.45205020904541016},{"id":"https://openalex.org/C112930515","wikidata":"https://www.wikidata.org/wiki/Q4389547","display_name":"Risk analysis (engineering)","level":1,"score":0.37215888500213623},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3592706322669983},{"id":"https://openalex.org/C160735492","wikidata":"https://www.wikidata.org/wiki/Q31207","display_name":"Health care","level":2,"score":0.33975422382354736},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.30804795026779175},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.13910579681396484},{"id":"https://openalex.org/C17744445","wikidata":"https://www.wikidata.org/wiki/Q36442","display_name":"Political science","level":0,"score":0.08542829751968384},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0},{"id":"https://openalex.org/C199539241","wikidata":"https://www.wikidata.org/wiki/Q7748","display_name":"Law","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:3105953293","doi":null,"is_oa":false,"landing_page_url":"https://www.iomcworld.org/articles/pharmacovigilance-2019-process-optimization-and-role-of-artificial-intelligence-in-globalpharmacovigilance.pdf","pdf_url":null,"source":{"id":"https://openalex.org/S2764552476","display_name":"International Journal of Applied Biology and P","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"International Journal of Applied Biology and P","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9391000270843506}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2066240751","https://openalex.org/W4394808180","https://openalex.org/W3196731983","https://openalex.org/W4318046707","https://openalex.org/W4390101590","https://openalex.org/W2614419535","https://openalex.org/W6968076065","https://openalex.org/W3212714550","https://openalex.org/W4412962901","https://openalex.org/W2592933852"],"abstract_inverted_index":{"Pharmacovigilance":[0,139,219,241],"is":[1,16,59,140,153,242,280,302,325],"like":[2],"a":[3,17,54,221,227,373],"sunshade":[4],"to":[5,50,61,69,112,126,246,295,304,368,379],"describe":[6],"the":[7,44,52,71,86,110,174,177,233,262,272,288,300,307,332,337,344,360,370],"processes":[8],"for":[9,164,223,250,354],"monitoring":[10,167,189],"and":[11,14,27,49,103,143,149,188,204,208,212,225,232,255,322,336,351],"evaluating":[12],"ADRs":[13],"it":[15,152],"key":[18],"component":[19],"of":[20,33,46,57,81,97,146,176,185,190,210,229,290,309,313,334,339,372],"effective":[21],"drug":[22,64,105,129,165,199,314],"regulation":[23],"systems,":[24],"clinical":[25,147,273],"practice":[26],"public":[28,114],"health":[29,115],"programs.":[30],"The":[31,77,311],"number":[32],"Adverse":[34],"Drug":[35],"Reactions":[36],"(ADRs)":[37],"reported":[38],"resulted":[39],"in":[40,43,155,168,183,216,244,261,271,293,306,317,366,377],"an":[41,74,94,141],"increase":[42],"volume":[45],"data":[47],"handled,":[48],"understand":[51],"pharmacovigilance,":[53],"high":[55],"level":[56],"expertise":[58],"required":[60],"rapidly":[62],"detect":[63,127],"risks":[65],"as":[66,68,220],"well":[67,259,282],"defend":[70],"product":[72],"against":[73],"inappropriate":[75],"removal.":[76],"current":[78],"global":[79,170],"network":[80],"pharmacovigilance":[82,121,160,179,202,211,266,335,348],"centers,":[83],"coordinated":[84],"by":[85,93],"Uppsala":[87],"Monitoring":[88],"Centre,":[89],"would":[90,100],"be":[91,305],"strengthened":[92],"independent":[95],"system":[96],"review.":[98],"This":[99,329],"consider":[101],"litigious":[102],"important":[104,142,361],"safety":[106,166,187,224,249,315,375,383],"issues":[107,231,316],"that":[108,131,257,297,347,363],"have":[109],"potential":[111],"affect":[113],"adversely":[116],"beyond":[117],"national":[118],"boundaries.":[119],"Recently,":[120],"has":[122,349],"been":[123],"confined,":[124],"mainly":[125],"adverse":[128,277,291,340],"events":[130],"were":[132],"previously":[133],"either":[134],"unknown":[135],"or":[136,284],"poorly":[137],"understood.":[138],"integral":[144],"part":[145],"research":[148],"these":[150],"days":[151],"growing":[154],"many":[156,159],"countries.":[157],"Today":[158],"centers":[161,203],"are":[162,258,268,298],"working":[163],"this":[169,193],"pitch,":[171],"however,":[172],"at":[173],"turn":[175],"millennium":[178],"faces":[180],"major":[181],"challenges":[182,209,235],"aspect":[184],"better":[186],"drugs.":[191],"In":[192],"review":[194,228,330],"we":[195],"will":[196],"discuss":[197],"about":[198],"safety,":[200],"worldwide":[201],"their":[205],"role,":[206],"benefits":[207],"its":[213],"future":[214],"consideration":[215],"healthcare":[217],"sectors.":[218],"tool":[222],"monitoring:":[226],"general":[230],"specific":[234],"with":[236,319],"end-stage":[237],"renal":[238],"failure":[239],"patients":[240,318,358],"instrumental":[243],"helping":[245,367],"ensure":[247],"patient":[248,382],"both":[251],"newly":[252],"released":[253],"drugs":[254,296],"those":[256],"established":[260],"market.":[263],"However,":[264],"while":[265],"procedures":[267],"strictly":[269],"regulated":[270],"trial":[274],"setting,":[275],"post-marketing":[276],"event":[278,341],"reporting":[279],"not":[281],"implemented":[283],"enforced.":[285],"As":[286],"such,":[287],"underreporting":[289],"events,":[292],"relation":[294],"on":[299],"market,":[301],"estimated":[303],"region":[308],"90%.":[310],"identification":[312],"complex":[320],"diseases":[321],"extensive":[323],"comorbidities":[324],"therefore":[326],"particularly":[327],"challenging.":[328],"defines":[331],"science":[333],"process":[338],"reporting,":[342],"highlights":[343],"new":[345],"directions":[346],"taken,":[350],"provides":[352],"insight":[353],"HCPs":[355],"managing":[356],"dialysis":[357],"into":[359],"role":[362],"they":[364],"play":[365],"shape":[369],"understanding":[371],"drug\u2019s":[374],"profile":[376],"order":[378],"continually":[380],"enhance":[381]},"counts_by_year":[],"updated_date":"2025-10-10T17:16:08.811792","created_date":"2020-11-23T00:00:00"}